Search Results

240 results for bmti

3 Iconic Brands Offering Both 5% Yields and 50% Upside at Current P/Es

By Steve Booyens, CFA

Although potential value traps must be considered, high-dividend value stocks are en masse. Consider these three stocks from iconic brands.

3 Dividend Stocks to Buy at a 52-Week Low in April

By Nikolaos Sismanis, InvestorPlace Contributor

Explore these three dividend stocks trading near their 52-week lows, presenting compelling opportunities for income-oriented investors.

3 Dividend Stocks That Are Just Doomed

By Steve Booyens, CFA

Overvalued dividend stocks are everywhere amid slower nominal earnings growth. Avoid or sell these three dividend stocks before they plummet.

3 High-Yield Dividend Stocks Worth Speculating On Now

By Josh Enomoto, InvestorPlace Contributor

Although it’s a risky venture, these high-yield dividend stocks are in a surprisingly strong position to reward patient investors.

Bristol-Myers Squibb Earnings: BMY Stock Jumps 2% on Q2 Beats

By Nick Clarkson, Web Editor

Bristol-Myers Squibb earnings on Thursday have BMY stock rising higher after the company beat EPS and revenue estimates from Wall Street.

Why Juniper Networks, Inc. (JNPR), Supervalu Inc. (SVU) and Bristol-Myers Squibb Co (BMY) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer

Juniper Networks (JNPR), Bristol-Myers Squibb (BMY) and Supervalu (SVU) lost their uphill battles they were forced to fight on Wednesday.

3 Big Pharma Stocks Under the Microscope: BMY, ABBV, LLY

By Profit Scanner

Are prevailing concerns about big pharma stocks taking their toll, or are LLY, BMY and ABBV showing their strength anyway?

ACB Stock Alert: What Is Going on With Aurora Cannabis Shares Today?

By Larry Ramer, InvestorPlace Contributor

ACB stock is falling in early trading after Aurora Cannabis announced that its CFO has resigned. Here’s what to know.

4 Pharmaceutical Stocks to Buy Now

By Portfolio Grader

This week, four Pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B”…

4 Pharmaceutical Stocks to Buy Now

By Portfolio Grader

The grades of four Pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong…

7 Consumer Stocks to Buy and Hold for the Long Haul

By Thomas Niel, InvestorPlace Contributor

So, what are some of the best long-term consumer stocks to buy today? Consider these seven. All of them are attractively-priced at present, and each…

7 Health Care Equipment & Supplies Stocks to Sell Now

By Portfolio Grader

This week, the ratings of 7 Health Care Equipment & Supplies stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or…

Celgene News: Why CELG Stock Is Surging Today

By William White, InvestorPlace Writer

Celgene news concerning the company’s ongoing deal with Bristol-Myers Squibb (BMS) has CELG stock on the rise for Friday.

Celgene Stock (CELG) Slides Lower on Opposition to Bristol-Meyers Deal

By William White, InvestorPlace Writer

Celgene stock was on its way down Thursday following news that major investors are against a deal with Bristol-Meyers (BMY).

10 Stocks to Watch Get Ready to Release Earnings

By Louis Navellier, Editor, Growth Investor

Earnings releases from 10 key stocks can effect your portfolio decisions, so keep an eye on them over the next two days.

3 Dividend Stocks for Strong Returns in 2024 and Beyond

By Bob Ciura, Sure Dividend

Investors should consider these three dividend stocks for 2024 and beyond, as they offer compelling yields and safety.

3 Starter Dividend Stocks Every New Investor Should Own

By Yiannis Zourmpanos, InvestorPlace Contributor

Explore the income potential and stability of this dividend stock trio in the industrial REITs, drug retail, and tobacco industries.

3 Undervalued Dividend Stocks to Buy Now to Beat the S&P 500

By Bob Ciura, Sure Dividend

If you want to outperform the S&P 500, consider these undervalued dividend stocks for juicy yields and high total return potential.

3 Sorry Pharma Stocks to Sell in August Before It’s Too Late

By Tyrik Torres, InvestorPlace Contributor

Factors in the marketplace caused these companies to underperform, making them some of the top pharma stocks to sell.

3 Big Stock Charts for Tuesday: Johnson & Johnson, Merck, and Bristol-Myers Squibb

By David Moadel, InvestorPlace Contributor

Tuesday’s big stock charts feature health-care-sector names that may offer value and leadership.

3 Cheap Healthcare Stocks to Buy Right Now

By David Cohne, StockNews.com

The Baby Boomers are getting older, which means investors should consider adding undervalued healthcare stocks to their portfolio.

7 Dividend Stocks That Should Be on Every Investor’s Radar This Fall

By Thomas Niel, InvestorPlace Contributor

Each of these seven dividend stocks to buy has a high (5% or more), sustainable yield, and trades at a favorable price

Fear Around Bristol-Myers Squibb Stock is Starting to Fade

By James Brumley, InvestorPlace Feature Writer

BMY stock may continue to bounce around, but the months-long selloff is now slowing because Bristol-Myers Squibb is still thriving.

3 Value Stocks to Consider for Your Diversified Portfolio

By Rich Duprey, InvestorPlace Contributor

Buying value stocks for diversification is smart because you reduce your risk while your portfolio capitalizes on a stock’s return to growth.

7 – 10 of 240 results